Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Teva, Allergan Settle San Francisco Opioid Claims For $54M

Legal
News

Teva, Allergan Settle San Francisco Opioid Claims For $54M

-Reuters

byBenzinga Newsdesk

July 12, 2022

1 minute read

-Reuters

Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

By Lara Goldstein

September 7, 6:29 PM

PharmaTher Holdings (OTCQB: PHRRF), the biopharma company developing novel uses and delivery forms of ketamine for mental health treatments, has completed an IND-enabling pharmacokinetic and tolerability study of its ketamine patch, KETARX, in minipigs.

PHRRF

Barclays Initiates Coverage On Shoals Technologies Gr with Equal-Weight Rating, Announces Price Target of $24

By Benzinga Newsdesk

August 5, 4:52 AM

Barclays analyst Christine Cho initiates coverage on Shoals Technologies Gr (NASDAQ:SHLS) with a Equal-Weight rating and announces Price Target of $24.

SHLS

Mercedes-Benz Accelerates Carbon-Neutral Efforts: Inks Power Purchase Agreement With Iberdrola

By Shivani Kumaresan

March 30, 1:22 PM

Mercedes Benz Group ADR (OTC:MBGYY) has concluded a power purchase agreement (PPA) with Spain’s renewable energy company, Iberdrola S.A. (OTC:IBDRY) (OTC:IBDSF). This contract…

IBDRY

Raymond James Downgrades CME Group to Market Perform

By Benzinga Newsdesk

August 15, 6:06 AM

Raymond James analyst Patrick O'Shaughnessy downgrades CME Group (NASDAQ:CME) from Outperform to Market Perform.

CME

Teva, Allergan Settle San Francisco Opioid Claims For $54M

Related Posts

Intradermal Ketamine Patch Completes Pre-Clinical Phase, Advances To Clinical Studies

Barclays Initiates Coverage On Shoals Technologies Gr with Equal-Weight Rating, Announces Price Target of $24

Mercedes-Benz Accelerates Carbon-Neutral Efforts: Inks Power Purchase Agreement With Iberdrola

Raymond James Downgrades CME Group to Market Perform